Maspin expression in stage I and II oral tongue squamous cell carcinoma

Ryuji Yasumatsu, Torahiko Nakashima, Naoya Hirakawa, Yoshihiko Kumamoto, Yuichiro Kuratomi, Kichinobu Tomita, Sohtaro Komiyama

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Background. A relatively high failure rate in the therapy of patients with early oral tongue squamous cell carcinomas (SCCs) is evidenced by untreated clinically negative neck lymph node metastasis. It is important to predict the malignant potential of oral tongue SCC in stage I and II patients, because the development of lymph node metastasis directly affects the prognosis of the patients. Methods. We evaluated maspin expression immunohistochemically in patients with stage I and II oral tongue SCCs and determined whether the expression level may be a useful factor in predicting metastatic potential and prognosis of these SCCs. Results. Clinical follow-up data showed a longer disease-free interval and overall survival periods for tumors immunohistochemically positive for maspin than for tumors negative for maspin, with the difference in disease-free interval being statistically significant (p = .01). The absence of maspin expression was found more frequently in cases of subsequent cervical lymph node metastasis than in cases without metastasis (p = .03). Conclusions. Decreased maspin expression may be a significant factor associated with the metastatic potential of stage I and II oral tongue SCCs.

Original languageEnglish
Pages (from-to)962-966
Number of pages5
JournalHead and Neck
Volume23
Issue number11
DOIs
Publication statusPublished - Oct 29 2001

Fingerprint

Tongue
Squamous Cell Carcinoma
Neoplasm Metastasis
Lymph Nodes
Neoplasms
Neck
SERPIN-B5
Survival
Therapeutics

All Science Journal Classification (ASJC) codes

  • Otorhinolaryngology

Cite this

Yasumatsu, R., Nakashima, T., Hirakawa, N., Kumamoto, Y., Kuratomi, Y., Tomita, K., & Komiyama, S. (2001). Maspin expression in stage I and II oral tongue squamous cell carcinoma. Head and Neck, 23(11), 962-966. https://doi.org/10.1002/hed.1139

Maspin expression in stage I and II oral tongue squamous cell carcinoma. / Yasumatsu, Ryuji; Nakashima, Torahiko; Hirakawa, Naoya; Kumamoto, Yoshihiko; Kuratomi, Yuichiro; Tomita, Kichinobu; Komiyama, Sohtaro.

In: Head and Neck, Vol. 23, No. 11, 29.10.2001, p. 962-966.

Research output: Contribution to journalArticle

Yasumatsu, R, Nakashima, T, Hirakawa, N, Kumamoto, Y, Kuratomi, Y, Tomita, K & Komiyama, S 2001, 'Maspin expression in stage I and II oral tongue squamous cell carcinoma', Head and Neck, vol. 23, no. 11, pp. 962-966. https://doi.org/10.1002/hed.1139
Yasumatsu R, Nakashima T, Hirakawa N, Kumamoto Y, Kuratomi Y, Tomita K et al. Maspin expression in stage I and II oral tongue squamous cell carcinoma. Head and Neck. 2001 Oct 29;23(11):962-966. https://doi.org/10.1002/hed.1139
Yasumatsu, Ryuji ; Nakashima, Torahiko ; Hirakawa, Naoya ; Kumamoto, Yoshihiko ; Kuratomi, Yuichiro ; Tomita, Kichinobu ; Komiyama, Sohtaro. / Maspin expression in stage I and II oral tongue squamous cell carcinoma. In: Head and Neck. 2001 ; Vol. 23, No. 11. pp. 962-966.
@article{61d1727590de428d94fee94982104545,
title = "Maspin expression in stage I and II oral tongue squamous cell carcinoma",
abstract = "Background. A relatively high failure rate in the therapy of patients with early oral tongue squamous cell carcinomas (SCCs) is evidenced by untreated clinically negative neck lymph node metastasis. It is important to predict the malignant potential of oral tongue SCC in stage I and II patients, because the development of lymph node metastasis directly affects the prognosis of the patients. Methods. We evaluated maspin expression immunohistochemically in patients with stage I and II oral tongue SCCs and determined whether the expression level may be a useful factor in predicting metastatic potential and prognosis of these SCCs. Results. Clinical follow-up data showed a longer disease-free interval and overall survival periods for tumors immunohistochemically positive for maspin than for tumors negative for maspin, with the difference in disease-free interval being statistically significant (p = .01). The absence of maspin expression was found more frequently in cases of subsequent cervical lymph node metastasis than in cases without metastasis (p = .03). Conclusions. Decreased maspin expression may be a significant factor associated with the metastatic potential of stage I and II oral tongue SCCs.",
author = "Ryuji Yasumatsu and Torahiko Nakashima and Naoya Hirakawa and Yoshihiko Kumamoto and Yuichiro Kuratomi and Kichinobu Tomita and Sohtaro Komiyama",
year = "2001",
month = "10",
day = "29",
doi = "10.1002/hed.1139",
language = "English",
volume = "23",
pages = "962--966",
journal = "Head and Neck Surgery",
issn = "1043-3074",
publisher = "John Wiley and Sons Inc.",
number = "11",

}

TY - JOUR

T1 - Maspin expression in stage I and II oral tongue squamous cell carcinoma

AU - Yasumatsu, Ryuji

AU - Nakashima, Torahiko

AU - Hirakawa, Naoya

AU - Kumamoto, Yoshihiko

AU - Kuratomi, Yuichiro

AU - Tomita, Kichinobu

AU - Komiyama, Sohtaro

PY - 2001/10/29

Y1 - 2001/10/29

N2 - Background. A relatively high failure rate in the therapy of patients with early oral tongue squamous cell carcinomas (SCCs) is evidenced by untreated clinically negative neck lymph node metastasis. It is important to predict the malignant potential of oral tongue SCC in stage I and II patients, because the development of lymph node metastasis directly affects the prognosis of the patients. Methods. We evaluated maspin expression immunohistochemically in patients with stage I and II oral tongue SCCs and determined whether the expression level may be a useful factor in predicting metastatic potential and prognosis of these SCCs. Results. Clinical follow-up data showed a longer disease-free interval and overall survival periods for tumors immunohistochemically positive for maspin than for tumors negative for maspin, with the difference in disease-free interval being statistically significant (p = .01). The absence of maspin expression was found more frequently in cases of subsequent cervical lymph node metastasis than in cases without metastasis (p = .03). Conclusions. Decreased maspin expression may be a significant factor associated with the metastatic potential of stage I and II oral tongue SCCs.

AB - Background. A relatively high failure rate in the therapy of patients with early oral tongue squamous cell carcinomas (SCCs) is evidenced by untreated clinically negative neck lymph node metastasis. It is important to predict the malignant potential of oral tongue SCC in stage I and II patients, because the development of lymph node metastasis directly affects the prognosis of the patients. Methods. We evaluated maspin expression immunohistochemically in patients with stage I and II oral tongue SCCs and determined whether the expression level may be a useful factor in predicting metastatic potential and prognosis of these SCCs. Results. Clinical follow-up data showed a longer disease-free interval and overall survival periods for tumors immunohistochemically positive for maspin than for tumors negative for maspin, with the difference in disease-free interval being statistically significant (p = .01). The absence of maspin expression was found more frequently in cases of subsequent cervical lymph node metastasis than in cases without metastasis (p = .03). Conclusions. Decreased maspin expression may be a significant factor associated with the metastatic potential of stage I and II oral tongue SCCs.

UR - http://www.scopus.com/inward/record.url?scp=0034761728&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034761728&partnerID=8YFLogxK

U2 - 10.1002/hed.1139

DO - 10.1002/hed.1139

M3 - Article

C2 - 11754500

AN - SCOPUS:0034761728

VL - 23

SP - 962

EP - 966

JO - Head and Neck Surgery

JF - Head and Neck Surgery

SN - 1043-3074

IS - 11

ER -